Presentation AATS 2013

Commercialization of TAVR in the US: What is the Strategy?

Presenter: Kristen Skelton

May 08, 2013

REGISTER for free or LOG IN to view this content

Commercialization of TAVR in the US: What is the Strategy?

Aortic Valve

Presentation

AATS 2013

Up Next

Presentation

Biodegradable Polymer BES vs. Durable Polymer EES: A Randomized, Controlled, Non-inferiority Trial

Presenter: 221201|Masahiro Natsuaki

May 08, 2013

More slides +

Presentation

POSEIDON: Sliding Scale Hydration for the Prevention of Contrast-Induced AKI

Presenter: Somjot S. Brar

May 09, 2013

Presentation

Angioplasty Following Carotid Stent Deployment Reduces the Risk of Restenosis and May or May Not Increase the Risk of Procedure-Related Stroke

Presenter: Mahmoud B. Malas

May 09, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.